Author:
Aribi Ahmed,Bueso-Ramos Carlos,Estey Eli,Estrov Zeev,O'Brien Susan,Giles Francis,Faderl Stefan,Thomas Deborah,Kebriaei Partow,Garcia-Manero Guillermo,Pierce Sherry,Cortes Jorge,Kantarjian Hagop,Ravandi Farhad
Reference12 articles.
1. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia;Baer;Seminars in Oncology,1993
2. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL);Bene;Leukemia,1995
3. Lineage commitment in biphenotypic acute leukemia;Buccheri;Leukemia,1993
4. Cyclophosphamide, ara-C and topotecan (CAT) for patients with refractory or relapsed acute leukemia;Cortes;Leukemia & Lymphoma,2000
5. High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia;Cortes;Cancer,2001
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献